AU3693397A - Oral pharmaceutical combinations of antihistaminic compounds and terpenoids - Google Patents

Oral pharmaceutical combinations of antihistaminic compounds and terpenoids

Info

Publication number
AU3693397A
AU3693397A AU36933/97A AU3693397A AU3693397A AU 3693397 A AU3693397 A AU 3693397A AU 36933/97 A AU36933/97 A AU 36933/97A AU 3693397 A AU3693397 A AU 3693397A AU 3693397 A AU3693397 A AU 3693397A
Authority
AU
Australia
Prior art keywords
terpenoids
oral pharmaceutical
pharmaceutical combinations
antihistaminic compounds
antihistaminic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36933/97A
Inventor
Uwe Rolf Jurgens
Beat Schmid
Werner Tschollar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Original Assignee
Novartis Consumer Health SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health SA filed Critical Novartis Consumer Health SA
Priority claimed from ZA976144A external-priority patent/ZA976144B/en
Publication of AU3693397A publication Critical patent/AU3693397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
AU36933/97A 1996-07-10 1997-07-09 Oral pharmaceutical combinations of antihistaminic compounds and terpenoids Abandoned AU3693397A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96810444 1996-07-10
EP96810444 1996-07-10
PCT/EP1997/003625 WO1998001134A1 (en) 1996-07-10 1997-07-09 Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
ZA976144A ZA976144B (en) 1996-07-10 1997-07-10 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU3693397A true AU3693397A (en) 1998-02-02

Family

ID=26144224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36933/97A Abandoned AU3693397A (en) 1996-07-10 1997-07-09 Oral pharmaceutical combinations of antihistaminic compounds and terpenoids

Country Status (2)

Country Link
AU (1) AU3693397A (en)
WO (1) WO1998001134A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4194196B2 (en) 1999-02-22 2008-12-10 花王株式会社 Bath agent composition
WO2002096870A2 (en) * 2001-05-31 2002-12-05 The Regents Of The University Of California Sponge-derived terpenoids and methods of use
JP4549609B2 (en) * 2002-04-11 2010-09-22 エスエス製薬株式会社 Coated solid hypnotic formulation
US6720423B2 (en) 2002-04-30 2004-04-13 Allergan, Inc. Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
DE10229472A1 (en) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Compact milk lactate ester
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
JP2006342188A (en) 2006-09-28 2006-12-21 Rohto Pharmaceut Co Ltd Intraoral dissolution type or chewable solid internal medicine composition for treating rhinitis
JP5884396B2 (en) * 2010-11-10 2016-03-15 ライオン株式会社 Formulation for improving airway inflammation
DE102012218733A1 (en) * 2012-10-15 2014-04-17 Beiersdorf Ag Cosmetic or dermatological preparation for the prophylaxis and / or treatment of atopic dermatitis
JP2013032408A (en) * 2012-11-22 2013-02-14 Rohto Pharmaceutical Co Ltd Orally dissolution type or mandibulate type rhinitis treatment solid internal pharmaceutical formulation
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63255219A (en) * 1987-04-11 1988-10-21 Teikoku Seiyaku Kk Antipruritic plaster
JPH02205A (en) * 1987-11-09 1990-01-05 Taisho Pharmaceut Co Ltd Perfume-containing coating agent for soft capsule
EP0421825A1 (en) * 1989-08-11 1991-04-10 Kadem Farmaseutiese Produktie B.K. Paracetamol solutions
AU5134893A (en) * 1992-10-09 1994-05-09 Procter & Gamble Company, The Anaesthetic compositions
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
EP0725630A1 (en) * 1993-10-28 1996-08-14 The Procter & Gamble Company Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
JPH07242536A (en) * 1994-03-01 1995-09-19 Toyo Capsule Kk Gelatin capsule agent containing essential oil component in skin

Also Published As

Publication number Publication date
WO1998001134A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU3445697A (en) New use of xylitol and pharmaceutical compositions therefor
AU3265695A (en) Novel naphthyridine derivative and medicinal composition thereof
HUP0203374A3 (en) Sold oral pharmaceutical composition and process for its preparation
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU5136998A (en) Medicinal composition
AUPN411195A0 (en) Medicinal composition
AU5880498A (en) New benzolactam derivatives and medicinal compositions containing the same
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
AU6856094A (en) Oxadiazole derivative and medicinal composition thereof
AU3888597A (en) Oral contraceptive
AU3693397A (en) Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
AU3444297A (en) Oral pharmaceutical combinations of nsaids with terpenoids
AUPN801196A0 (en) New cephem compounds and pharmaceutical use thereof
AU7735798A (en) Pharmaceutical composition for oral administration
AU3460897A (en) Medicinal compositions
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
AU3961697A (en) Oral contraceptive
AU7681498A (en) Pharmaceutical composition and use thereof
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
AU2896897A (en) Oral pharmaceutical compositions
AU2815897A (en) Oral contraceptive
AU1195597A (en) Dibenzothiepin derivatives and pharmaceutical compositions
AU2975997A (en) Substituted amidinobenzene derivatives and medicinal compositions thereof